SP
BravenNow
Barclays reiterates Overweight on ConAgra stock, $21 target
| USA | economy | ✓ Verified - investing.com

Barclays reiterates Overweight on ConAgra stock, $21 target

📚 Related People & Topics

Barclays

Barclays

British multinational banking and financial services company

Barclays PLC (, occasionally ) is a British multinational universal bank, headquartered in London, England. Barclays operates as five divisions: the UK Consumer Bank, UK Corporate Bank, Private Bank and Wealth Management (PBWM), Investment Bank, and the US Consumer Bank. Barclays traces its origins ...

View Profile → Wikipedia ↗

Conagra Brands

American multinational consumer packaged goods holding company

Conagra Brands, Inc. (formerly ConAgra Foods) is an American consumer packaged goods holding company that makes and sells products under various brand names that are available in supermarkets, restaurants, and food service establishments. Based on its 2021 revenue, the company ranked 331st on the 20...

View Profile → Wikipedia ↗
Overweight

Overweight

Above a weight considered healthy

Being overweight is having more body fat than is considered healthy. The World Health Organization (WHO) classifies people as overweight when their body mass index (BMI)—a person's weight divided by the square of the person's height—is between 25–30 kg/m2; BMIs above 30 kg/m2 are defined as obese. B...

View Profile → Wikipedia ↗

Entity Intersection Graph

Connections for Barclays:

🌐 Middle East 2 shared
🌐 Artificial intelligence 2 shared
👤 Derwent London 2 shared
🌐 Nike 2 shared
🌐 Iran 2 shared
View full profile

Mentioned Entities

Barclays

Barclays

British multinational banking and financial services company

Conagra Brands

American multinational consumer packaged goods holding company

Overweight

Overweight

Above a weight considered healthy

Deep Analysis

Why It Matters

This news matters because Barclays' reiteration of an Overweight rating signals continued confidence in ConAgra's stock performance, potentially influencing investor decisions and market sentiment. As a major food manufacturer with brands like Healthy Choice, Slim Jim, and Birds Eye, ConAgra's valuation affects shareholders, employees, and consumers. The $21 price target provides a benchmark for investors assessing whether the stock is undervalued or overvalued relative to current trading levels.

Context & Background

  • ConAgra Brands is one of North America's largest packaged food companies with a portfolio of well-known consumer brands
  • Barclays is a major global investment bank whose analyst ratings can significantly influence institutional and retail investor behavior
  • Overweight ratings typically indicate analysts believe the stock will outperform the market or its sector peers over a specified period
  • Food manufacturing stocks have faced challenges from inflation, supply chain issues, and changing consumer preferences in recent years
  • Analyst price targets represent projections of where a stock might trade within a 12-18 month timeframe based on financial analysis

What Happens Next

Investors will watch ConAgra's next earnings report to see if performance aligns with Barclays' positive outlook. Market reaction may include increased trading volume as investors adjust positions based on the reiterated rating. ConAgra management may reference analyst confidence in upcoming investor communications, and competing analysts may issue their own updated ratings in response.

Frequently Asked Questions

What does an Overweight rating mean?

An Overweight rating means analysts believe the stock will perform better than the average return of the market or its sector. It's essentially a 'buy' recommendation suggesting investors should allocate more portfolio weight to this stock than to comparable investments.

Why would Barclays reiterate an existing rating?

Analysts typically reiterate ratings when their fundamental thesis remains unchanged despite market movements or new developments. This signals continued confidence in their original analysis and suggests recent events haven't altered their positive outlook on the company.

How significant is a $21 price target?

The significance depends on ConAgra's current trading price. If trading below $21, it suggests potential upside; if above, it suggests the stock may be overvalued. The target represents Barclays' estimate of fair value based on financial projections and industry comparisons.

Who is most affected by this news?

Current ConAgra shareholders benefit from analyst confidence that may support the stock price. Potential investors get guidance for decision-making, while ConAgra management may use positive analyst coverage in investor relations. Competitors monitor such ratings for market sentiment insights.

How reliable are analyst price targets?

Price targets are educated estimates based on financial modeling, not guarantees. They can be influenced by changing market conditions, unexpected company developments, or broader economic factors. Investors typically consider multiple analyst opinions rather than relying on a single target.

}
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Trump says Iranian "president" has asked U.S. for ceasefire Oil oscillates around $100 as Trump says Iran war could end soon Now up 169%+: A new list of AI-picked stocks for April IS NOW LIVE Markets are too aggressive on Fed hikes, Goldman says (South Africa Philippines Nigeria) Barclays reiterates Overweight on ConAgra stock, $21 target By Analyst Ratings Published 04/01/2026, 10:52 AM Barclays reiterates Overweight on ConAgra stock, $21 target 0 CAG -2.80% Investing.com - Barclays reiterated an Overweight rating and $21.00 price target on ConAgra Brands Inc. (NYSE:CAG) following the company’s third-quarter fiscal 2026 results. ConAgra reported organic sales that exceeded consensus estimates with modest improvements in gross margin and EBIT. Earnings per share came in one cent below Street expectations, primarily due to lower than forecasted equity method earnings from the Ardent Mills joint venture.The stock currently trades at $15.26, just 1% above its 52-week low of $15.04, reflecting a challenging year with shares down 36% over the past twelve months. According to InvestingPro analysis, ConAgra appears undervalued at current levels, with the company’s strong free cash flow yield of 12% and dividend yield of 8.91% offering compelling income potential for investors. The company narrowed its fiscal 2026 guidance with one quarter remaining in the fiscal year. ConAgra now expects organic sales growth at the midpoint of its previous range of -1% to +1% year-over-year, compared to consensus of -0.5% year-over-year. Operating margin is expected near the high end of the previous range of approximately 11.0% to 11.5%. Earnings per share guidance was set at the low end of the previous range of $1.70 to $1.85, compared to consensus of $1.72. Management noted a $0.10 headwind from Ardent Mills relative to its original fiscal 2026 assumption. The company raised its free cash flow conversion estimate for the full year...
Read full article at source

Source

investing.com

More from USA

News from Other Countries

🇬🇧 United Kingdom

🇺🇦 Ukraine